Judit H. Nyirady Joins LEO Pharma as VP of Medical Strategy & Scientific Affairs

Judit H. Nyirady, M.D., M.B.A. has joined LEO Pharma as Vice President of Medical Strategy & Scientific Affairs.  Dr. Nyirady will be responsible for the medical and scientific affairs strategies for LEO Pharma in the United States, as well as the U.S. Quality, Pharmacovigilance, Drug Safety, and Medical Information functions.

Judit H. Nyirady, M.D., MBA

"Dr. Nyirady joins LEO Pharma U.S. with extensive clinical development and scientific affairs credentials, and a proven record of accomplishments," Joergen Damsbo Andersen, interim President and CEO of LEO Pharma Inc. said. "She will play a critical role in achieving LEO Pharma's mission to help people suffering from skin diseases," Joergen Damsbo Andersen, interim President and CEO of LEO Pharma."

Nyirady is a board certified dermatologist with over 18 years of pharmaceutical experience in all aspects of clinical research and development.  She also has medical affairs expertise within both systemic and topical drugs.

Prior to joining LEO Nyirady worked at Novartis, most recently as interim Medical Unit Head of Dermatology & Immunology, U.S. Clinical Development & Medical Affairs and concurrently as the Executive Director, Dermatology, U.S. Clinical Development & Medical Affairs.  Before joining Novartis in 2003, Dr. Nyirady worked at Johnson & Johnson Consumer Products Worldwide (CPWW) as Director of Medical Affairs, Dermatology.

Nyirady holds a M.B.A. from Cornell University, Johnson Graduate School of Management and obtained her medical degree in Hungary from Albert Szent-Györgyi Medical University.